Summary Fifty patients with iron-deficiency anaemia were treated by total-dose infusion of iron-dextran. The therapeutic response was satisfactory in all cases. No severe systemic side effects occurred. In ten patients in whom detailed investigations were made there was no change in erythrocyte sedimentation rate or blood coagulation nor was there evidence of haemolysis following the iron-dextran infusion. No difficulty was found in ABO and Rh blood grouping and cross matching after infusion.
No takes yet. Share an insight, caveat, or question.
Groden et al. (1968) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: